PECAM (ECs) cell marke and TAGLN (SMC marker) have been used to assess reendothelialization rate of endothelial cells in several cardiovascular disease studies (Hutter et al., 2003; Ouyang et al., 2021). Here, TAGLN is linked to cardiovascular disorder.